Mutated telomeres sensitize tumor cells to anticancer drugs independently of telomere shortening and mechanisms of telomere maintenance
Open Access
- 12 June 2006
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 25 (56) , 7411-7420
- https://doi.org/10.1038/sj.onc.1209727
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Extratelomeric Functions of TelomeraseCurrent Molecular Medicine, 2005
- The role of apoptosis in cancer development and treatment responseNature Reviews Cancer, 2005
- Cell death by mitotic catastrophe: a molecular definitionOncogene, 2004
- Telomerase in the human organismOncogene, 2002
- Telomere maintenance by telomerase and by recombination can coexist in human cellsHuman Molecular Genetics, 2001
- The length of telomeric G-rich strand 3'-overhang measured by oligonucleotide ligation assayNucleic Acids Research, 2001
- Telomere maintenance by recombination in human cellsNature Genetics, 2000
- Attenuation of telomerase activity does not increase sensitivity of human melanoma cells to anticancer agentsEuropean Journal Of Cancer, 2000
- Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell linesNature Medicine, 1997
- The RNA Component of Human TelomeraseScience, 1995